Jeffrey M. Leiden - 12 Feb 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Executive Chairman, Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
12 Feb 2025
Net transactions value
-$1,138,346
Form type
4
Filing time
14 Feb 2025, 16:17:12 UTC
Previous filing
06 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Award $0 +7,209 +28% $0.000000 32,617 12 Feb 2025 Direct F1
transaction VRTX Common Stock Tax liability $1,138,346 -2,525 -7.7% $450.83 30,092 13 Feb 2025 Direct
holding VRTX Common Stock 440 12 Feb 2025 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award that fully vested upon grant.